VEGFA and Sepsis: In the model of CLP-induced sepsis used herein, EPA-preconditioned AD-MSCs yielded greater therapeutic benefits in comparison to nonpreconditioned AD-MSCs by further reducing lung mechanics and histological abnormalities, inflammation, collagen fiber content, and morphological alterations in distal organs, while increasing VEGF levels in lung tissue.